Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Disclosure on signing as PTSC is a Public Company.

Hoping Ron or someone elase maybe able to address this once and for all. I keep hearing that some of the singing are not disclosed. This makes no sense to me as PTSC is a public company in which Alliacense represents in these filings. Would PTSC not have to disclose their earning after each qtr ? of is it just not publicly displaying who paid what??

Patriot Scientific (OTC Bulletin Board: PTSC) and The TPL Group have unified their interests in a portfolio of fundamental microprocessor patents that are at the heart of a global microprocessor end-use market. The unification was achieved through a joint venture established via agreements entered into between Patriot Scientific and TPL in June 2005. Patriot and TPL each own 50% of the joint venture and share in the proceeds of licensing activities as distributed by the joint venture pursuant to the agreements. Alliacense, a TPL Group entity, is responsible for the commercialization and licensing of this patent portfolio.

<!-- <p>Founded in 1988, Silicon Valley-based TPL has a solid track record in delivering a complete suite of intellectual property management services. In addition to optimizing IP portfolio value and protecting assets from infringement, the company is also well versed in converting portfolio value into a maximum cash return for its owner(s). Through Alliacense, the TPL Group manages IP-licensing programs across a broad array of industries.</p> <p>Alliacense is a TPL Group Enterprise executing best-in-class design and implementation of intellectual property licensing programs. As a cadre of IP-licensing strategists, technology experts, and experienced business development/management executives, Alliacense focuses on expanding the awareness and value of TPL's intellectual property portfolios.</p> -->

The patent portfolio, marketed as the Moore Microprocessor Patent (MMP) Portfolio, contains intellectual property that is jointly owned by the publicly held Patriot Scientific Corporation and the privately held TPL Group. The portfolio encompasses several U.S. patents as well as their European and Japanese counterparts. Both TPL and Patriot assert that their jointly owned patents protect techniques used in designing microprocessors, microcontrollers, digital signal processors (DSPs), embedded processors, and system-on-chip (SoC) implementations. Patriot Scientific and TPL believe at least three of the patents are elemental to virtually every microprocessor design. The three most significant of these patents are as follows:

U.S. 5,809,336: Clocking CPU and I/O Separately

U.S. 6,598,148: Use of Multiple Cores and Embedded Memory

  • U.S. 5,784,584: Multiple Instruction Fetch
  • Both Patriot Scientific and The TPL Group assert that these patents, which were granted in 1998 and which are valid through 2015, have long been essential to the design of modern high-speed microprocessors.

    So we are waiting on ITC, complete markman ruling and the T3 case.

    Share
    New Message
    Please login to post a reply